These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25277199)

  • 21. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
    Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
    Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
    Wang ZQ; Bachvarova M; Morin C; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Bachvarov D
    Oncotarget; 2014 Jan; 5(2):544-60. PubMed ID: 24504219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study.
    Elzarkaa AA; Sabaa BE; Abdelkhalik D; Mansour H; Melis M; Shaalan W; Farouk M; Malik E; Soliman AA
    J Cancer Res Clin Oncol; 2016 May; 142(5):949-58. PubMed ID: 26762850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis.
    Liu R; Martin TA; Jordan NJ; Ruge F; Ye L; Jiang WG
    Int J Oncol; 2015 Oct; 47(4):1429-39. PubMed ID: 26316204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
    Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
    Wang FQ; Fisher J; Fishman DA
    Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis.
    Tsofack SP; Meunier L; Sanchez L; Madore J; Provencher D; Mes-Masson AM; Lebel M
    BMC Cancer; 2013 Jun; 13():303. PubMed ID: 23800275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.
    Webb JR; Milne K; Kroeger DR; Nelson BH
    Gynecol Oncol; 2016 May; 141(2):293-302. PubMed ID: 26972336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ezrin overexpression by transformed human ovarian surface epithelial cells, ovarian cleft cells, and serous ovarian adenocarcinoma cells.
    Fadiel A; Chen Z; Ulukus E; Ohtani K; Hatami M; Naftolin F
    Reprod Sci; 2012 Aug; 19(8):797-805. PubMed ID: 22477337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer.
    Gaudin F; Nasreddine S; Donnadieu AC; Emilie D; Combadière C; Prévot S; Machelon V; Balabanian K
    PLoS One; 2011; 6(7):e21546. PubMed ID: 21750716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.
    Xiao X; Yang G; Bai P; Gui S; Nyuyen TM; Mercado-Uribe I; Yang M; Zou J; Li Q; Xiao J; Chang B; Liu G; Wang H; Liu J
    BMC Cancer; 2016 Aug; 16():582. PubMed ID: 27484466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer.
    Meng Q; Duan P; Li L; Miao Y
    Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression and prognostic relevance of Bmi-1, a stem cell factor, in epithelial ovarian cancer.
    Abd El hafez A; El-Hadaad HA
    Ann Diagn Pathol; 2014 Apr; 18(2):58-62. PubMed ID: 24342665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells.
    Zhou Q; Yu Y
    Med Sci Monit; 2015 Nov; 21():3409-14. PubMed ID: 26546806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
    Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
    Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells.
    Wang ZQ; Keita M; Bachvarova M; Gobeil S; Morin C; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Trinh XB; Bachvarov D
    PLoS One; 2013; 8(10):e74384. PubMed ID: 24124450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of CD157 contributes to epithelial ovarian cancer progression by promoting mesenchymal differentiation.
    Morone S; Lo-Buono N; Parrotta R; Giacomino A; Nacci G; Brusco A; Larionov A; Ostano P; Mello-Grand M; Chiorino G; Ortolan E; Funaro A
    PLoS One; 2012; 7(8):e43649. PubMed ID: 22916288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
    Leng R; Liao G; Wang H; Kuang J; Tang L
    Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.